1. Home
  2. BENF vs GCTK Comparison

BENF vs GCTK Comparison

Compare BENF & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BENF
  • GCTK
  • Stock Information
  • Founded
  • BENF 2003
  • GCTK 2001
  • Country
  • BENF United States
  • GCTK United States
  • Employees
  • BENF N/A
  • GCTK N/A
  • Industry
  • BENF Blank Checks
  • GCTK Medical/Dental Instruments
  • Sector
  • BENF Finance
  • GCTK Health Care
  • Exchange
  • BENF Nasdaq
  • GCTK Nasdaq
  • Market Cap
  • BENF 2.6M
  • GCTK 3.3M
  • IPO Year
  • BENF N/A
  • GCTK N/A
  • Fundamental
  • Price
  • BENF $0.41
  • GCTK $4.26
  • Analyst Decision
  • BENF
  • GCTK
  • Analyst Count
  • BENF 0
  • GCTK 0
  • Target Price
  • BENF N/A
  • GCTK N/A
  • AVG Volume (30 Days)
  • BENF 7.2M
  • GCTK 36.1K
  • Earning Date
  • BENF 09-09-2025
  • GCTK 08-14-2025
  • Dividend Yield
  • BENF N/A
  • GCTK N/A
  • EPS Growth
  • BENF N/A
  • GCTK N/A
  • EPS
  • BENF N/A
  • GCTK N/A
  • Revenue
  • BENF N/A
  • GCTK N/A
  • Revenue This Year
  • BENF N/A
  • GCTK N/A
  • Revenue Next Year
  • BENF $53.55
  • GCTK N/A
  • P/E Ratio
  • BENF N/A
  • GCTK N/A
  • Revenue Growth
  • BENF N/A
  • GCTK N/A
  • 52 Week Low
  • BENF $0.22
  • GCTK $4.22
  • 52 Week High
  • BENF $3.33
  • GCTK $3,756.00
  • Technical
  • Relative Strength Index (RSI)
  • BENF 60.92
  • GCTK 31.52
  • Support Level
  • BENF $0.33
  • GCTK $4.22
  • Resistance Level
  • BENF $0.65
  • GCTK $5.64
  • Average True Range (ATR)
  • BENF 0.06
  • GCTK 0.35
  • MACD
  • BENF 0.01
  • GCTK -0.12
  • Stochastic Oscillator
  • BENF 35.71
  • GCTK 8.43

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.

Share on Social Networks: